All news

UBS starts AbCellera at buy on menopause drug

Alpha Vantage · Investing.com Canada · · AI-summarised by FinFlash

UBS initiated coverage on AbCellera Biologics with a Buy rating and an

Read original source

ABCL company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.